Part of our mission as a community for those impacted by gynecologic cancers is to inform and educate our followers regarding new developments in disease screening, treatment and survivorship.
A number of those developments were presented as research studies and practice innovations during the SGO Annual Meeting in New Orleans in March. This 49th Annual Meeting drew over 2500 participants including gynecologic oncologists, oncologists, radiologists, genetic counselors, oncology nurses and patient advocates. The #gyncsm community will discuss research projects and trial results presented at this meeting during our monthly chat on April 11, 2018 at 9pm ET (8pm CT, 6pm PT).
Join us as we cover a variety of research topics including answering questions such as:
What is the impact minimally invasive surgery has had on survival of women diagnosed with early stage cervical cancer?
What is the latest news on the use of targeted therapies (niraparib, pemrolizumab, Olaparib, durvalumab) in treating ovarian cancer?
What impact could Phase I trial of Vigil® vaccine personalized engineered autologous tumor cells (EATC) have on preventing recurrence in women with ovarian cancer ?
What is the role of palliative care and lay navigators in treating and supporting gyn cancer survivors ?
What is the impact of chemotherapy and radiotherapy on endometrial cancer survival?
How can we improve funding for gyn cancer research?
What is the impact of participation in clinical trials on minority patients?
During the chat we will open the discussion to questions participants have for our health care professionals.
Check the SGO Facebook page (https://www.facebook.com/SGO.org/), their Twitter account (@SGO_org and #SGOmtg), or their website (https://www.sgo.org/education/annual-meeting-on-womens-cancer/annual-meeting-media-coverage-3/) for more meeting coverage and potential topics of interest.
We look forward to having you join us.
Dee
#gyncsm co-moderator
No comments:
Post a Comment